Background illustration for clinical trials search

Paid Clinical Trials Fort Worth

Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Dallas TX, Austin TX, Westwood KS, St Louis MO,
Sponsor: Deciphera Pharmaceuticals, LLC

Sex: All

Age: 18+

Code: NCT06619561

Phase 2, Recruiting

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for
Diffuse Large B-Cell Lymphoma
Location: Dallas TX, The Woodlands TX, Houston TX, Lubbock TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06717347

Phase 3, Recruiting

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

for
Heart Failure, Acute Heart Failure
Location: Dallas TX, Plano TX, Bartlesville OK, Austin TX,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06008197

Phase 3, Recruiting

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

for
Chronic Migraine
Location: Waxahachie TX, Austin TX, Houston TX, Little Rock AR,
Sponsor: AbbVie

Sex: All

Age: 12 - 17

Code: NCT06810505

Phase 3, Recruiting

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohn Disease
Location: Dallas TX, Tyler TX, Cedar Park TX, Bellaire TX,
Sponsor: Abivax S.A.

Sex: All

Age: 18 - 70+

Code: NCT06456593

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

for
Acne
Location: Carrollton TX, Dallas TX, Katy TX, Prosper TX,
Sponsor: Sanofi Pasteur, a Sanofi Company

Sex: All

Age: 18 - 45

Code: NCT06316297

Phase 1, Phase 2, Recruiting

IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL

for
Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT06768905

Phase 1, Phase 2, Recruiting

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

for
Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF),
Location: Dallas TX, Houston TX, Little Rock AR, St Louis MO,
Sponsor: Cytokinetics

Sex: All

Age: 40 - 70+

Code: NCT06793371

Phase 2, Recruiting

A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)

for
Phenylketonuria (PKU)
Location: Dallas TX, New Orleans LA, Aurora CO, Nashville TN,
Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 0+

Code: NCT05813678

Recruiting

Blue Light Cystoscopy With Cysview® Registry

for
Bladder Cancer
Location: Dallas TX, Houston TX, Kansas City KS, Birmingham AL,
Sponsor: Photocure

Sex: All

Age: 18+

Code: NCT02660645

Recruiting

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

for
Renal Cell Carcinoma
Location: Dallas TX, Lubbock TX, St Louis MO, Lone Tree CO,
Sponsor: HiberCell, Inc.

Sex: All

Age: 18+

Code: NCT06234605

Phase 1, Recruiting

A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

for
Coagulation Disorder
Location: Dallas TX, Tulsa OK, Arkansas City AR, Englewood CO,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT05156983

Phase 3, Recruiting

Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

for
Abdominal Aortic Aneurysm,
Location: Plano TX, Houston TX, Wichita KS, Denver CO, Atlanta GA,
Sponsor: Medtronic Cardiovascular

Sex: All

Age: 20+

Code: NCT05378347

Recruiting

COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

for
Complex Congenital Heart Defect, Dysfunctional RVOT Conduit,
Location: Dallas TX, San Antonio TX, Little Rock AR, Memphis TN,
Sponsor: Edwards Lifesciences

Sex: All

Age: 0+

Code: NCT02744677

Recruiting

A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma

for
Advanced Hepatocellular Carcinoma
Location: Dallas TX, Houston TX, Chicago IL, Charlotte NC,
Sponsor: Iterion Therapeutics

Sex: All

Age: 18+

Code: NCT05797805

Phase 1, Phase 2, Recruiting

Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury

for
Acute Kidney Injury
Location: Dallas TX, Shreveport LA, San Antonio TX,
Sponsor: SeaStar Medical

Sex: All

Age: 18+

Code: NCT05758077

Recruiting

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Dallas TX, Grand Island NE, Daphne AL, Lone Tree CO,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06095505

Phase 2, Recruiting

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

for
Neurofibromatosis Type 1
Location: Dallas TX, St Louis MO, Birmingham AL, Aurora CO,
Sponsor: Healx Limited

Sex: All

Age: 12+

Code: NCT06541847

Phase 2, Recruiting

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

for
Autoimmune Hepatitis, Primary Sclerosing Cholangitis
Location: Dallas TX, St Louis MO, Indianapolis IN, Chicago IL,
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0+

Code: NCT05750498

Recruiting

Early Routine Bowel Preparation for Suspected Acute Diverticular Bleeding

for
Diverticular Bleeding
Location: Dallas TX
Sponsor: Methodist Health System

Sex: All

Age: 18+

Code: NCT05170945

Recruiting